Article Text

Download PDFPDF
Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy
  1. Minoru Yasudaa,
  2. Sakan Maedab,
  3. Toshio Kawamataa,
  4. Akira Tamaokad,
  5. Yasuji Yamamotoc,
  6. Shigetoshi Kurodae,
  7. Kiyoshi Maedaa,c,
  8. Chikako Tanakaa
  1. aHyogo Institute for Aging Brain and Cognitive Disorders, Himeji, Japan, bDepartment of Pathology, Kobe University School of Medicine, Kobe, Japan , cDepartment of Psychiatry and Neurology, dDepartment of Neurology, Institute of Clinical Medicine, University of Tsukuba, Japan, eDepartment of Neuropsychiatry, Okayama University Medical School, Okayama Japan
  1. Dr Minoru Yasuda, Hyogo Institute for Aging Brain and Cognitive Disorders, 520 Saisho-ko, Himeji 670–0981, Japan email yasuda{at}hiabcd.go.jp

Abstract

OBJECTIVE To clarify the phenotypic heterogeneity in deposition of amyloid beta (Aβ) in the parenchyma and in cerebral vessels of the brains of the patients having presenilin-1 (PS1) mutations. Mutations in PS1 induce increased production of Aβ42(43), resulting in an enhanced overall deposition of Aβ protein within the cerebral cortex.

METHODS Sequence analysis of the PS1 gene of DNA from patients with early onset Alzheimer's disease, and immunostaining of brain tissues by end specific monoclonal antibodies against Aβ.

RESULTS Sequence analysis disclosed a novel mutation (N405S) in the PS1 gene in a Japanese patient with early-onset Alzheimer's disease. Postmortem examination of one patient with N405S showed limited cerebral amyloid angiopathy, whereas postmortem examination of another Japanese patient with Alzheimer's disease with the E184D mutation disclosed severe cerebral amyloid angiopathy. The brains of both patients showed widespread neuritic plaques, neurofibrillary tangles, and neuronal loss. Immunostaining showed that Aβ42 was predominant over Aβ40 in neuritic plaques in both patients, whereas Aβ40 was found to be predominant over Aβ42 in cerebral amyloid angiopathy in the patient with E184D. However, most cortical vessels of the patient with N405S were not reactive with either of the antibodies.

CONCLUSION The N405S mutation of PS1 is a major determinant of cortical Aβ deposition but not cerebral amyloid angiopathy in Alzheimer's disease.

  • presenilin-1
  • mutation
  • Alzheimer's disease
  • amyloid angiopathy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes